Leadership Overview
Amgen has 10 executives leading key functions including information technology, financial strategy, business performance, commercial operations, strategic planning, patient access, team leadership, risk engineering, and product operations.
Driven by a commitment to scientific innovation, Amgen advances human health through the development of transformative biotechnology therapies for patients worldwide.
Driven by a commitment to scientific innovation, Amgen advances human health through the development of transformative biotechnology therapies for patients worldwide.
Leadership Roles at Amgen
Marianela Capelli - Chief Financial Officer (Argentina)
Marianela Capelli, the Chief Financial Officer (Argentina) at Amgen, manages fiscal health and resource allocation across South American operations. Overseeing regional budget planning, the Chief Financial Officer (Argentina) ensures strict adherence to corporate financial policies while navigating complex local regulatory environments. This leadership role involves optimizing capital expenditure to support regional market expansion and product distribution. By analyzing economic trends, Capelli drives cost-efficiency initiatives that bolster the bottom line within the Latin American sector. The Chief Financial Officer (Argentina) coordinates with global finance teams to maintain transparency and reporting accuracy. Through meticulous oversight of regional assets, Marianela Capelli secures the financial stability necessary for sustained growth, enabling the company to maintain a competitive edge in the biotechnology landscape while delivering essential medical solutions to the regional patient population.
Peter Griffith - Executive VP & Chief Financial Officer
Peter Griffith, the Executive VP & Chief Financial Officer at Amgen, directs the global financial strategy and capital allocation for the entire organization. Overseeing the integrity of financial reporting, the Executive VP & Chief Financial Officer ensures that the company maintains a robust balance sheet to fund long-term research and development. This leadership role involves managing investor relations and communicating the financial health of the enterprise to stakeholders. By optimizing the capital structure, Griffith supports the acquisition of new technologies and the expansion of manufacturing capabilities. The Executive VP & Chief Financial Officer collaborates with the board to set fiscal targets that drive sustainable growth across all international markets. Through disciplined financial management, Peter Griffith secures the resources necessary for the company to continue pioneering the biotechnology industry, ensuring that scientific innovation remains supported by a stable and efficient economic foundation.
Scott Skellenger - Senior VP & Chief Information Officer
Scott Skellenger, the Senior VP & Chief Information Officer at Amgen, directs the global digital infrastructure supporting complex biotechnology research. Overseeing enterprise-wide data architecture, the Senior VP & Chief Information Officer ensures secure integration of clinical trial information across international research hubs. This leadership role involves modernizing cloud platforms to accelerate drug discovery timelines while maintaining rigorous compliance standards. By implementing advanced analytics, Skellenger optimizes operational efficiency throughout the manufacturing lifecycle. The Senior VP & Chief Information Officer collaborates with executive leadership to align technological investments with long-term scientific goals. Through the deployment of scalable software solutions, Scott Skellenger strengthens the digital backbone of the organization, facilitating seamless collaboration between laboratory teams and global supply chain networks to deliver life-saving therapies to patients in diverse markets.
Gabriela Lavezzari - Business Performance Chief of Staff
Gabriela Lavezzari, the Business Performance Chief of Staff at Amgen, coordinates cross-functional initiatives to enhance organizational productivity. Overseeing the execution of strategic business objectives, the Business Performance Chief of Staff aligns departmental workflows with the overarching mission of scientific excellence. This leadership role involves facilitating communication between executive leadership and operational teams to streamline decision-making processes. By monitoring key performance indicators, Lavezzari identifies opportunities for process improvement across the global enterprise. The Business Performance Chief of Staff manages high-priority projects that directly impact the speed of product development and market delivery. Through the synthesis of operational data, Gabriela Lavezzari drives accountability and efficiency, ensuring that internal resources remain focused on high-impact activities that support the company's position as a leader in the biotechnology industry while fostering a culture of continuous improvement.
Eric Chamblee - Director. Chief of Staff for Senior Vice President Commercial, Obesity and Related Conditions
Eric Chamblee, the Director. Chief of Staff for Senior Vice President Commercial, Obesity and Related Conditions at Amgen, manages the strategic agenda for the commercial division focused on metabolic health. Overseeing the integration of market insights, the Director. Chief of Staff for Senior Vice President Commercial, Obesity and Related Conditions ensures that commercial strategies effectively address the needs of patients suffering from obesity and related conditions. This leadership role involves coordinating with marketing and sales teams to drive product adoption in competitive global markets. By facilitating executive alignment, Chamblee supports the development of targeted outreach programs that expand patient access to innovative treatments. The Director. Chief of Staff for Senior Vice President Commercial, Obesity and Related Conditions monitors commercial performance metrics to refine tactical execution. Through these efforts, Eric Chamblee accelerates the commercialization of critical therapies, directly contributing to the company's growth in the metabolic health sector.
Katherine Rizos - Director, Strategic Planning & Operations & To The Chief of Staff & Chief Information Officer
Katherine Rizos, the Director, Strategic Planning & Operations & To The Chief of Staff & Chief Information Officer at Amgen, architects the operational framework for the information technology division. Overseeing the alignment of strategic planning with technical execution, the Director, Strategic Planning & Operations & To The Chief of Staff & Chief Information Officer ensures that IT initiatives support the broader biotechnology research mission. This leadership role involves managing complex operational budgets and resource allocation to maximize the impact of digital investments. By streamlining internal processes, Rizos enhances the agility of the technology team in responding to evolving scientific requirements. The Director, Strategic Planning & Operations & To The Chief of Staff & Chief Information Officer facilitates communication between the CIO and other executive leaders to ensure cohesive strategy implementation. Through rigorous planning, Katherine Rizos drives the operational excellence required to maintain the company's technological leadership in the global biotech market.
Stephanie Camstra - Strategic Planning Operations, Patient Access & Reimbursement To Chief of Staff (US) & Vice President
Stephanie Camstra, the Strategic Planning Operations, Patient Access & Reimbursement To Chief of Staff (US) & Vice President at Amgen, leads initiatives to improve patient access to essential biotechnology therapies within the United States. Overseeing the development of reimbursement strategies, the Strategic Planning Operations, Patient Access & Reimbursement To Chief of Staff (US) & Vice President ensures that patients can obtain necessary treatments through effective engagement with healthcare providers and payers. This leadership role involves analyzing market access barriers and designing operational solutions to overcome them. By coordinating with internal teams, Camstra aligns strategic planning with the goal of expanding the reach of the company's product portfolio. The Strategic Planning Operations, Patient Access & Reimbursement To Chief of Staff (US) & Vice President monitors policy changes to adapt commercial strategies proactively. Through these efforts, Stephanie Camstra facilitates broader patient access, ensuring that the company's medical innovations reach those who need them most.
Rene Marquina - Senior Engineer & Chief People Officer, Risk Engineering
Rene Marquina, the Senior Engineer & Chief People Officer, Risk Engineering at Amgen, directs the technical risk assessment and human capital strategy within the engineering division. Overseeing the implementation of safety protocols, the Senior Engineer & Chief People Officer, Risk Engineering ensures that all manufacturing and research processes meet the highest standards of operational integrity. This leadership role involves managing the talent pipeline for specialized engineering roles while mitigating technical risks associated with complex biotechnology production. By integrating risk management into the organizational culture, Marquina enhances the reliability of the company's infrastructure. The Senior Engineer & Chief People Officer, Risk Engineering collaborates with cross-functional teams to ensure that human capital development supports the technical requirements of the business. Through rigorous oversight, Rene Marquina maintains the operational safety and technical excellence required to sustain the company's leadership in the global biotechnology sector.
Valentina Guarino - Manager, Combination Product Operations (Chief People Officer)
Valentina Guarino, the Manager, Combination Product Operations (Chief People Officer) at Amgen, oversees the production and personnel management for advanced combination products. Overseeing the integration of device and drug manufacturing, the Manager, Combination Product Operations (Chief People Officer) ensures that complex delivery systems meet stringent quality and regulatory standards. This leadership role involves managing the workforce responsible for the assembly and testing of these specialized medical products. By optimizing production workflows, Guarino enhances the efficiency of the supply chain for critical patient-facing technologies. The Manager, Combination Product Operations (Chief People Officer) coordinates with quality assurance teams to maintain compliance and safety throughout the manufacturing process. Through the development of skilled personnel and the refinement of operational procedures, Valentina Guarino ensures the reliable delivery of high-quality combination products, supporting the company's commitment to improving patient outcomes through innovative medical device and therapy integration.
Lisa Fries - Team Captain
Lisa Fries, the Team Captain at Amgen, leads specialized project groups focused on optimizing internal team dynamics and operational output. Overseeing the coordination of cross-functional talent, the Team Captain ensures that collaborative efforts remain aligned with the company's scientific objectives. This leadership role involves fostering a high-performance culture that encourages innovation and problem-solving within the research and development departments. By facilitating communication and resource sharing, Fries enhances the efficiency of project execution across various biotechnology initiatives. The Team Captain monitors team progress and addresses operational bottlenecks to maintain momentum on critical development timelines. Through the application of effective leadership techniques, Lisa Fries drives team cohesion and productivity, ensuring that the collective expertise of the staff is fully leveraged to advance the company's mission of delivering transformative therapies to patients in need across the global healthcare landscape.
Explore Leadership Teams in Manufacturing
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacturing, and commercialization of novel botulinum toxin products for various aesthetic and therapeutic indications. The company's lead drug candidate is DaxibotulinumtoxinA for injection (RT002), which is in Phase III clinical trials to treat glabellar (frown) lines, as well as in Phase II clinical trials for the treatment of cervical dystonia and plantar fasciitis. It is also developing DaxibotulinumtoxinA topical gel (RT001) that is in preclinical development. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was founded in 1999 and is headquartered in Newark,...
Company Leadership
SK
MA
Emcure Pharmaceuticals Limited is a global pharmaceutical company engaged in the research, development, manufacturing, and marketing of a broad range of pharmaceutical products and healthcare solutions. Headquartered in Pune, India, the organization operates as an international pharmaceutical enterprise with a strong presence in both domestic and global healthcare markets. The company focuses on delivering innovative and affordable medicines that address a wide spectrum of medical conditions and therapeutic needs across the healthcare sector. The organization is driven by a research-focused strategy that emphasizes innovation, scientific advancement, and the development of effective therapeutic solutions. Through its research and development capabilities, Emcure Pharmaceuticals works to discover and formulate medicines that address unmet medical needs and improve patient outcomes. The company’s research initiatives focus on areas such as complex generics, biosimilars, biologics, and specialized pharmaceutical formulations. These research efforts allow the organization to continuously introduce improved therapies and drug delivery systems designed to enhance treatment effectiveness and patient safety.
Company Leadership SM
DG
Humanetics Corporation is a clinical-stage pharmaceutical company engaged in the accelerated discovery, development, and commercialization of proprietary drugs in markets with urgent and unmet needs with a focus on medical countermeasures, radiation modulators for oncology and inflammatory lung diseases.
Company Leadership BL
KN
SC
AS
PT. Inertia Utama is a company that works within the pharmaceutical industry. The company is based in Tangerang Selatan, Indonesia.
Company Leadership HS
WW
FS
Frequently Asked Questions Regarding Amgen Top Executives and Leadership Team
Unlock more people and company data
